Rallybio Corporation (RLYB) Earnings Dates & History
NASDAQ·Healthcare·Biotechnology
$15.60
-0.95%
Mkt Cap $56.84M
EPS — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 12, 2026 | $100.00K | $222.00K | +122.00% | -$1.24 | -$1.28 | -3.23% |
| Q4 2025 Nov 6, 2025 | $66.67K | $212.00K | +218.00% | -$0.25 | -$0.14 | +44.00% |
| Q3 2025 Aug 7, 2025 | $66.67K | $212.00K | +217.98% | -$0.20 | -$0.22 | -12.82% |
| Q2 2025 May 8, 2025 | — | $212.00K | — | -$0.21 | -$0.21 | +0.00% |
| Q1 2025 Mar 13, 2025 | $149.50K | $38.00K | -74.58% | -$0.27 | -$0.25 | +7.41% |
| Q4 2024 Nov 7, 2024 | $75.00K | $299.00K | +298.67% | -$0.36 | -$0.26 | +27.78% |
| Q3 2024 Aug 8, 2024 | — | $299.00K | — | -$0.42 | -$0.37 | +11.90% |
| Q2 2024 May 9, 2024 | — | — | — | -$0.50 | -$0.47 | +6.00% |
| Q1 2024 Mar 12, 2024 | — | $228.00K | — | -$0.44 | -$0.50 | -13.64% |
| Q4 2023 Nov 9, 2023 | — | — | — | -$0.51 | -$0.45 | +11.76% |
| Q3 2023 Aug 8, 2023 | — | — | — | -$0.48 | -$0.46 | +4.17% |
| Q2 2023 May 9, 2023 | — | — | — | -$0.50 | -$0.43 | +14.00% |
| Q1 2023 Mar 6, 2023 | — | — | — | -$0.63 | -$0.46 | +26.98% |
| Q4 2022 Nov 7, 2022 | — | — | — | -$0.54 | -$0.60 | -11.11% |
| Q3 2022 Aug 8, 2022 | — | — | — | -$0.61 | -$0.57 | +6.56% |
| Q2 2022 May 10, 2022 | — | — | — | -$0.48 | -$0.48 | +0.00% |
| Q1 2022 Mar 15, 2022 | — | — | — | -$0.39 | -$0.42 | -7.69% |
| Q4 2021 Nov 10, 2021 | — | — | — | -$0.89 | -$0.37 | +58.43% |
| Q3 2021 Sep 9, 2021 | — | — | — | -$2.80 | -$2.80 | +0.00% |
| Q1 2021 Mar 31, 2021 | — | — | — | — | -$4.77 | — |
| Q4 2020 Dec 31, 2020 | — | — | — | — | -$3.78 | — |
| Q3 2020 Sep 30, 2020 | — | — | — | — | -$2.57 | — |
| Q2 2020 Jun 30, 2020 | — | — | — | — | -$1.76 | — |
| Q1 2020 Mar 31, 2020 | — | — | — | — | -$1.40 | — |